• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在室温下储存6小时的解冻冷沉淀:作为连续输注的凝血因子VIII浓缩物的潜在替代品。

Thawed cryoprecipitate stored for 6 h at room temperature: a potential alternative to factor VIII concentrate for continuous infusion.

作者信息

Pesquera-Lepatan L M B, Hernandez F G, Lim R D, Chua M N

机构信息

Section of Pediatric Hematology-Oncology and the Hemophilia Center, University of Santo Tomas Hospital, Manila, Philippines.

出版信息

Haemophilia. 2004 Nov;10(6):684-8. doi: 10.1111/j.1365-2516.2004.01044.x.

DOI:10.1111/j.1365-2516.2004.01044.x
PMID:15569162
Abstract

Continuous infusion (CI) of factor VIII concentrates has been demonstrated to be cost-effective method in maintaining stable levels of FVIII activity in haemophilia A patients with major bleeding or undergoing major surgery. Cryoprecipitates remain the major source of FVIII in developing countries-like the Philippines because of limited availability and high cost of concentrates. To support the use of cryoprecipitate as alternative to FVIII concentrate for CI in centres with no factor concentrates, FVIII levels in 37 bags of random cryoprecipitate were measured at 0, 2, 4 and 6 h after thawing, kept at room temperature with bacteriological culture studies performed on the sixth hour. The mean FVIII content at hour 0 was 108.10 U per bag. Type ORh+ blood had lower FVIII content (+/-78.91 U per bag) compared with blood types ARh+ (+/-121.64 U per bag) and BRh+ (+/-117.04 U per bag). The units stored <6 months had higher FVIII content (+/-117.74 U per bag) compared with those stored for over 6- but <12-months (+/-66.77 U per bag). The mean rate of decline of FVIII activity at 2, 4 and 6 h was statistically significant at 10.35% (P = 0.000), 21.49% (P = 0.000) and 29.41% (P = 0.000) from baseline, respectively, using the paired t-test. Similar finding was found across different blood types and storage duration. Only one of 37 bags grew Staphylococcus aureus on day 10 of incubation.

摘要

对于患有严重出血或正在接受大手术的甲型血友病患者,持续输注(CI)凝血因子 VIII 浓缩物已被证明是维持 FVIII 活性稳定水平的一种经济有效的方法。由于浓缩物供应有限且成本高昂,在像菲律宾这样的发展中国家,冷沉淀仍然是 FVIII 的主要来源。为了支持在没有凝血因子浓缩物的中心使用冷沉淀替代 FVIII 浓缩物进行持续输注,对 37 袋随机抽取的冷沉淀在解冻后 0、2、4 和 6 小时测量 FVIII 水平,将其保存在室温下,并在第 6 小时进行细菌培养研究。第 0 小时时每袋冷沉淀的平均 FVIII 含量为 108.10 单位。与 A Rh+血型(每袋±121.64 单位)和 B Rh+血型(每袋±117.04 单位)相比,O Rh+血型的 FVIII 含量较低(每袋±78.91 单位)。储存时间<6 个月的冷沉淀单位 FVIII 含量(每袋±117.74 单位)高于储存 6 个月以上但<12 个月的冷沉淀(每袋±66.77 单位)。使用配对 t 检验,FVIII 活性在 2、4 和 6 小时相对于基线的平均下降率分别具有统计学意义,为 10.35%(P = 0.000)、21.49%(P = 0.000)和 29.41%(P = 0.000)。在不同血型和储存时间内发现了类似的结果。在培养第 10 天,37 袋冷沉淀中只有 1 袋培养出金黄色葡萄球菌。

相似文献

1
Thawed cryoprecipitate stored for 6 h at room temperature: a potential alternative to factor VIII concentrate for continuous infusion.在室温下储存6小时的解冻冷沉淀:作为连续输注的凝血因子VIII浓缩物的潜在替代品。
Haemophilia. 2004 Nov;10(6):684-8. doi: 10.1111/j.1365-2516.2004.01044.x.
2
Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.冷沉淀和新鲜冰冻血浆中凝血因子 XIII 含量及浓度的比较。
Transfusion. 2009 Apr;49(4):765-70. doi: 10.1111/j.1537-2995.2008.02021.x. Epub 2008 Dec 15.
3
A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.一种在血液中心使用一次性袋系统对冷沉淀进行溶剂-去污剂处理的微池工艺。
Vox Sang. 2006 Jul;91(1):56-62. doi: 10.1111/j.1423-0410.2006.00772.x.
4
In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion.通过持续输注递送超纯凝血因子VIII浓缩物期间的体外凝血因子VIII回收率。
Am J Hematol. 1996 Feb;51(2):99-103. doi: 10.1002/(SICI)1096-8652(199602)51:2<99::AID-AJH1>3.0.CO;2-1.
5
Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections.与大剂量注射相比,对甲型血友病儿童持续输注凝血因子浓缩剂。
Haemophilia. 2006 May;12(3):212-7. doi: 10.1111/j.1365-2516.2006.01217.x.
6
Factor VIII: C (FVIII: C) recovery and half-life after infusion of steam-treated high purity factor VIII concentrate in severe hemophilia A--comparison of one-stage assay, two-stage assay and a chromogenic substrate assay.重度甲型血友病患者输注经蒸汽处理的高纯度凝血因子 VIII 浓缩物后凝血因子 VIII:C(FVIII:C)的回收率及半衰期——一期法检测、二期法检测与发色底物法检测的比较
Thromb Haemost. 1986 Dec 15;56(3):353-9.
7
Lyophilized cryoprecipitate for children with hemophilia A.
J Med Assoc Thai. 2002 Jun;85 Suppl 1:S293-7.
8
Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma-derived factor VIII.在日本血友病 A 患者的全关节置换术中进行连续输注:两种重组因子 VIII 和一种血浆源性因子 VIII 的比较研究。
Haemophilia. 2010 Sep 1;16(5):740-6. doi: 10.1111/j.1365-2516.2010.02244.x. Epub 2010 Apr 12.
9
Stability of ADVATE, Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method, during simulated continuous infusion.ADVATE(重组抗血友病因子,无血浆/白蛋白法)在模拟持续输注过程中的稳定性。
Blood Coagul Fibrinolysis. 2006 Apr;17(3):165-71. doi: 10.1097/01.mbc.0000220236.92219.08.
10
Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors.
Haemophilia. 2004 Jul;10(4):341-6. doi: 10.1111/j.1365-2516.2004.00907.x.